Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis in Vitro

Stem Cells and Development

Volumn 24, Issue 14, 2015, Pages 1635-1647

  Shabbir, Arsalan ^a   Cox, Audrey ^a   Rodriguez Menocal, Luis ^a   Salgado, Marcela ^a   Van Badiavas, Evangelos ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A1; CYCLIN D2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; NERVE GROWTH FACTOR; PROTEIN KINASE B; SCATTER FACTOR; SOMATOMEDIN C; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; CXCL12 PROTEIN, HUMAN; HGF PROTEIN, HUMAN; IGF1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; NGF PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CHRONIC WOUND; COCULTURE; CONTROLLED STUDY; DNA BINDING; EXOSOME; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; INTRACELLULAR SIGNALING; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MULTIVESICULAR BODY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING; AGED; CELL CULTURE; CELL MOTION; CYTOLOGY; DIABETES MELLITUS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGED; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; DIABETES MELLITUS; EXOSOMES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; STAT3 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 84934297053     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0316     Document Type: Article

References (76)

1. Sen CK, GM Gordillo, S Roy, R Kirsner, L Lambert, TK Hunt, F Gottrup, GC Gurtner and MT Longaker. (2009). Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen 17: 763-771.
2. Mustoe TA, K O'Shaughnessy and O Kloeters. (2006). Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast Reconstr Surg 117: 35S-41S.
3. Velnar T, T Bailey and V Smrkolj. (2009). The wound healing process: An overview of the cellular and molecular mechanisms. J Int Med Res 37:1528-1542.
4. Robson MC, DL Steed and MG Franz. (2001). Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg 38:72-140.
5. Baum CL and CJ Arpey. (2005). Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31:674-686; discussion 686.
6. Galiano RD, OM Tepper, CR Pelo, KA Bhatt, M Callaghan, N Bastidas, S Bunting, HG Steinmetz and GC Gurtner. (2004). Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrowderived cells. Am J Pathol 164:1935-1947.
7. Brem H and M Tomic-Canic. (2007). Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117: 1219-1222.
8. Lerman OZ, RD Galiano, M Armour, JP Levine and GC Gurtner. (2003). Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162:303-312.
9. Loots MA, EN Lamme, JR Mekkes, JD Bos and E Middelkoop. (1999). Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 291:93-99.
10. Fahey TJ, 3rd, A Sadaty, WG Jones, 2nd, A Barber, B Smoller and GT Shires. (1991). Diabetes impairs the late inflammatory response to wound healing. J Surg Res 50: 308-313.
11. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
12. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
13. Jackson WM, LJ Nesti and RS Tuan. (2012). Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med 1: 44-50.
14. Hanson SE, ML Bentz and P Hematti. (2010). Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 125:510-516.
15. Shabbir A, D Zisa, M Leiker, C Johnston, H Lin and T Lee. (2009). Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation. Transplantation 87: 1275-1282.
16. Shabbir A, D Zisa, H Lin, M Mastri, G Roloff, G Suzuki and T Lee. (2010). Activation of host tissue trophic factors through JAK-STAT3 signaling: A mechanism of mesenchymal stem cell-mediated cardiac repair. Am J Physiol Heart Circ Physiol 299:H1428-H1438.
17. Shabbir A, D Zisa, G Suzuki and T Lee. (2009). Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: A noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296:H1888-H1897.
18. Chen L, EE Tredget, PY Wu and Y Wu. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886.
19. Rodriguez-Menocal L, M Salgado, D Ford and E Van Badiavas. (2012). Stimulation of skin and wound fibroblast migration by mesenchymal stem cells derived from normal donors and chronic wound patients. Stem Cells Transl Med 1:221-229.
20. Vlassov AV, S Magdaleno, R Setterquist and R Conrad. (2012). Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820:940-948.
21. Camussi G, MC Deregibus, S Bruno, V Cantaluppi and L Biancone. (2010). Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838-848.
22. Valadi H, K Ekstrom, A Bossios, M Sjostrand, JJ Lee and JO Lotvall. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659.
23. Aga M, GL Bentz, S Raffa, MR Torrisi, S Kondo, N Wakisaka, T Yoshizaki, JS Pagano and J Shackelford. (2014). Exosomal HIF1alpha supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene.
24. Roccaro AM, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, LM Flores, F Campigotto, et al. (2013). BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123:1542-1555.
25. Théry C, S Amigorena, G Raposo and A Clayton. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3:Unit 3 22.
26. Hosseini-Beheshti E, S Pham, H Adomat, N Li and ES Tomlinson Guns. (2012). Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 11:863-885.
27. Chambers AE, PF Stanley, H Randeva and S Banerjee. (2011). Microvesicle-mediated release of soluble LH/hCG receptor (LHCGR) from transfected cells and placenta explants. Reprod Biol Endocrinol 9:64.
28. Yang L, XH Wu, D Wang, CL Luo and LX Chen. (2013). Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep 8:1272-1278.
29. Shifrin DA, Jr., M Demory Beckler, RJ Coffey and MJ Tyska. (2013). Extracellular vesicles: communication, coercion, and conditioning. Mol Biol Cell 24:1253-1259.
30. Stewart K, P Monk, S Walsh, CM Jefferiss, J Letchford and JN Beresford. (2003). STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: A comparative investigation in vitro. Cell Tissue Res 313: 281-290.
31. Gutierrez-Vazquez C, C Villarroya-Beltri, M Mittelbrunn and F Sanchez-Madrid. (2013). Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev 251:125-142.
32. Camacho L, P Guerrero and D Marchetti. (2013). Micro-RNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One 8:e73790.
33. van Balkom BW, OG de Jong, M Smits, J Brummelman, K den Ouden, PM de Bree, MA van Eijndhoven, DM Pegtel, W Stoorvogel, T Wurdinger and MC Verhaar. (2013). Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121:3997-4006, S1-S15.
34. Sohel MM, M Hoelker, SS Noferesti, D Salilew-Wondim, E Tholen, C Looft, F Rings, MJ Uddin, TE Spencer, K Schellander and D Tesfaye. (2013). Exosomal and nonexosomal transport of extra-cellular microRNAs in follicular fluid: implications for bovine oocyte developmental competence. PLoS One 8:e78505.
35. Liang CC, AY Park and JL Guan. (2007). In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329-333.
36. Squarize CH, RM Castilho, TH Bugge and JS Gutkind. (2010). Accelerated wound healing by mTOR activation in genetically defined mouse models. PLoS One 5:e10643.
37. Sano S, KS Chan and J DiGiovanni. (2008). Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1-14.
38. Sharma GD, J He and HE Bazan. (2003). p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 278:21989-21997.
39. Dauer DJ, B Ferraro, L Song, B Yu, L Mora, R Buettner, S Enkemann, R Jove and EB Haura. (2005). Stat3 regulates genes common to both wound healing and cancer. Oncogene 24:3397-3408.
40. Funamoto M, Y Fujio, K Kunisada, S Negoro, E Tone, T Osugi, H Hirota, M Izumi, K Yoshizaki, et al. (2000). Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem 275:10561-10566.
41. Wojcik EJ, S Sharifpoor, NA Miller, TG Wright, R Watering, EA Tremblay, K Swan, CR Mueller and BE Elliott. (2006). A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Oncogene 25:2773-2784.
42. Huang WL, HH Yeh, CC Lin, WW Lai, JY Chang, WT Chang and WC Su. (2010). Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: A biochemical and genetic study of es-tablished cancer cell lines and clinical isolated human cancer cells. Mol Cancer 9:309.
43. Badiavas EV and V Falanga. (2003). Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 139:510-516.
44. Badiavas AR and EV Badiavas. (2011). Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing. Expert Opin Biol Ther 11:1447-1454.
45. Badiavas EV. (2004). The potential of bone marrow cells to orchestrate homeostasis and healing in skin. Blood Cells Mol Dis 32:21-23.
46. Badiavas EV, M Abedi, J Butmarc, V Falanga and P Quesenberry. (2003). Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196: 245-250.
47. Badiavas EV, D Ford, P Liu, N Kouttab, J Morgan, A Richards and A Maizel. (2007). Long-term bone marrow culture and its clinical potential in chronic wound healing. Wound Repair Regen 15:856-865.
48. Kean TJ, P Lin, AI Caplan and JE Dennis. (2013). MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int 2013: 732742.
49. Jun EK, Q Zhang, BS Yoon, JH Moon, G Lee, G Park, PJ Kang, JH Lee, A Kim and S You. (2014). Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-beta/SMAD2 and PI3K/Akt pathways. Int J Mol Sci 15:605-628.
50. Tamama K and SS Kerpedjieva. (2012). Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells. Adv Wound Care (New Rochelle) 1:177-182.
51. Tamari M, Y Nishino, N Yamamoto and M Ueda. (2013). Acceleration of wound healing with stem cell-derived growth factors. Int J Oral Maxillofac Implants 28:e369-e375.
52. Walter MN, KT Wright, HR Fuller, S MacNeil and WE Johnson. (2010). Mesenchymal stem cell-conditioned medium accelerates skin wound healing: An in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 316:1271-1281.
53. Rustom A, R Saffrich, I Markovic, P Walther and HH Gerdes. (2004). Nanotubular highways for intercellular organelle transport. Science 303:1007-1010.
54. Lai RC, F Arslan, MM Lee, NS Sze, A Choo, TS Chen, M Salto-Tellez, L Timmers, CN Lee, et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214-222.
55. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20: 1053-1067.
56. Xin H, Y Li, Y Cui, JJ Yang, ZG Zhang and M Chopp. (2013). Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33:1711-1715.
57. Zhu YG, XM Feng, J Abbott, XH Fang, Q Hao, A Monsel, JM Qu, MA Matthay and JW Lee. (2014). Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32:116-125.
58. Brem H, MS Golinko, O Stojadinovic, A Kodra, RF Diegelmann, S Vukelic, H Entero, DL Coppock and M Tomic-Canic. (2008). Primary cultured fibroblasts derived from patients with chronic wounds: A methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. J Transl Med 6:75.
59. Greives MR, F Samra, SC Pavlides, KM Blechman, SM Naylor, CD Woodrell, C Cadacio, JP Levine, TA Bancroft, et al. (2012). Exogenous calreticulin improves diabetic wound healing. Wound Repair Regen 20:715-730.
60. Wall IB, R Moseley, DM Baird, D Kipling, P Giles, I Laffafian, PE Price, DW Thomas and P Stephens. (2008). Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol 128:2526-2540.
61. Wang CY, HB Yang, HS Hsu, LL Chen, CC Tsai, KS Tsai, TL Yew, YH Kao and SC Hung. (2012). Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med 6:559-569.
62. Guiducci S, M Manetti, E Romano, B Mazzanti, C Ceccarelli, S Dal Pozzo, AF Milia, S Bellando-Randone, G Fiori, et al. (2011). Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 70:2011-2021.
63. Oskowitz A, H McFerrin, M Gutschow, ML Carter and R Pochampally. (2011). Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6:215-225.
64. Bian S, L Zhang, L Duan, X Wang, Y Min and H Yu. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 92:387-397.
65. Kinnaird T, E Stabile, MS Burnett, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685.
66. Weil BR, TA Markel, JL Herrmann, AM Abarbanell and DR Meldrum. (2009). Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery 146:190-197.
67. Zisa D, A Shabbir, G Suzuki and T Lee. (2009). Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cellmediated cardiac repair. Biochem Biophys Res Commun 390:834-838.
68. Robson MC. (1997). The role of growth factors in the healing of chronic wounds. Wound Repair Regen 5: 12-17.
69. Lauer G, S Sollberg, M Cole, I Flamme, J Sturzebecher, K Mann, T Krieg and SA Eming. (2000). Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 115: 12-18.
70. Wu L, YP Xia, SI Roth, E Gruskin and TA Mustoe. (1999). Transforming growth factor-beta1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. Am J Pathol 154:301-309.
71. Fleissner F, Y Goerzig, A Haverich and T Thum. (2012). Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant 12:289-297.
72. Hakelien AM, HB Landsverk, JM Robl, BS Skalhegg and P Collas. (2002). Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat Biotechnol 20:460-466.
73. Jang YY, MI Collector, SB Baylin, AM Diehl and SJ Sharkis. (2004). Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6:532-539.
74. Dovrat S, M Caspi, A Zilberberg, L Lahav, A Firsow, H Gur and R Rosin-Arbesfeld. (2014). 14-3-3 and beta-catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway. Mol Oncol 8:894-911.
75. Tomasoni S, L Longaretti, C Rota, M Morigi, S Conti, E Gotti, C Capelli, M Introna, G Remuzzi and A Benigni. (2013). Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22:772-780.
76. Wu Y, S Huang, J Enhe and X Fu. (2012). Insights into bone marrow-derived mesenchymal stem cells safety for cutaneous repair and regeneration. Int Wound J 9:586-594.